Cargando…

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Veríssimo, D., Borges, M., Galhardo, J., Lopes, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Scientific Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164617/
http://dx.doi.org/10.1016/j.diabres.2022.109362
_version_ 1784720176472653824
author Veríssimo, D.
Borges, M.
Galhardo, J.
Lopes, L.
author_facet Veríssimo, D.
Borges, M.
Galhardo, J.
Lopes, L.
author_sort Veríssimo, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9164617
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Scientific Publishers
record_format MEDLINE/PubMed
spelling pubmed-91646172022-06-04 IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection Veríssimo, D. Borges, M. Galhardo, J. Lopes, L. Diabetes Res Clin Pract Article Elsevier Scientific Publishers 2022-04 2022-06-03 /pmc/articles/PMC9164617/ http://dx.doi.org/10.1016/j.diabres.2022.109362 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Veríssimo, D.
Borges, M.
Galhardo, J.
Lopes, L.
IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
title IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
title_full IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
title_fullStr IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
title_full_unstemmed IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
title_short IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
title_sort idf21-0463 type 1 diabetes with insulin resistance following sars-cov-2 infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164617/
http://dx.doi.org/10.1016/j.diabres.2022.109362
work_keys_str_mv AT verissimod idf210463type1diabeteswithinsulinresistancefollowingsarscov2infection
AT borgesm idf210463type1diabeteswithinsulinresistancefollowingsarscov2infection
AT galhardoj idf210463type1diabeteswithinsulinresistancefollowingsarscov2infection
AT lopesl idf210463type1diabeteswithinsulinresistancefollowingsarscov2infection